help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Biophys. J. BioFAST: First Published November 3, 2006. doi:10.1529/biophysj.106.092528
© 2006 by the Biophysical Society.


A more recent version of this article appeared on February 1, 2007.
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
biophysj.106.092528v1
92/3/798    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Ornjira Aruksakunwong
Maturos Malaisree
Panita Decha
Pornthep Sompornpisut
Vudhichai Parasuk
Somsak Pianwanit
Supot Hannongbua
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aruksakunwong, O.
Right arrow Articles by Hannongbua, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aruksakunwong, O.
Right arrow Articles by Hannongbua, S.

BIOPHYSICAL THEORY AND MODELING

On the Lower Susceptibility of Oseltamivir to Influenza Neuraminidase Subtype N1 than those in N2 and N9

Ornjira Aruksakunwong 1, Maturos Malaisree 1, Panita Decha 1, Pornthep Sompornpisut 1, Vudhichai Parasuk 1, Somsak Pianwanit 1 and Supot Hannongbua 1*

1 Computational Chemistry Unit Cell, Chulalongkorn University

* To whom correspondence should be addressed. E-mail: supot.h{at}chula.ac.th.

Submitted on July 5, 2006
Revised on August 9, 2006
Accepted on 6 October 2006


   Abstract
Aiming to understand at the molecular level why oseltamivir (OTV) cannot be used for inhibition of human influenza neuraminidase subtype N1 as effectively as for subtypes N2 and N9, molecular dynamics simulations were carried out for the three complexes, OTV-N1, OTV-N2 and OTV-N9. The 3D OTV-N2 and OTV-N9 initial structures were represented by the X-ray structures while that of OTV-N1, which its X-ray structure is not yet solved, was built up using the aligned sequence of H5N1 isolated from humans in Thailand with the X-ray structure of the N2-substrate as the template. In comparison to the OTV-N2 and OTV-N9 complexes, dramatic changes were observed on the OTV conformation in the OTV-N1 complex in which two of its bulky side chains, N-acethyl (-NHAc) and 1-ethylproxy group (-OCHEt2), were rotated in order to adjust its size to fit into the N1 catalytic site. This change leads directly to the rearrangements of the OTV's environment, which are: (i) Distances to its neighbors, W178 and E227, are shorter while those to residues R224, E276 and E292 are longer. (ii) Hydrogen bonds to the two nearest neighbors, R224 and E276, are still conserved in distance and number as well as percentage occupation. (iii) The calculated ligand/enzyme binding free energies of -7.20, -13.44 and -13.29 kcal/mol agree with their inhibitory activities in terms of the experimental IC50 of 36.1 - 53.2 nM, 1.9 - 2.7 nM and 9.5 - 17.7 nM for the OTV-N1, OTV-N2 and OTV-N9 complexes, respectively. (iv) Hydrogen bond breaking and creation between the OTV and neighborhood residues are accordingly in agreement with the ligand solvation/desolvation taking place in the catalytic site.

Key Words: Human Influenza, MD simulation, Neuraminidase N1, Oseltamivir




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
M. Holodniy, S. R. Penzak, T. M. Straight, R. T. Davey, K. K. Lee, M. B. Goetz, D. W. Raisch, F. Cunningham, E. T. Lin, N. Olivo, et al.
Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3013 - 3021.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the Biophysical Society.